體外擴增過程中CD34+細胞內B細胞特異單克隆鼠白血病毒整合位點基因1和人端粒酶逆轉錄酶基因的表達_《中國修復重建外科雜志》

作者：

葛劍云 , 蔡海波 , 杜錚 , 譚文松

作者單位：華東理工大學生物反應器工程國家重點實驗室（上海，200237）;

關鍵詞：

CD34+細胞體外擴增 B細胞特異單克隆鼠白血病毒整合位點基因1 人端粒酶逆轉錄酶

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的研究體外擴增過程中，CD34+細胞內B細胞特異單克隆鼠白血病毒整合位點基因1（B-cell-specific monoclonal leukemia virus insert site 1，Bmi1）和人端粒酶逆轉錄酶（human telomerase reverse transcriptase，hTERT）基因的表達水平與其擴增特性的相關性。方法采用含FBS、干細胞生長因子、Flt-3配體和促血小板生成素的IMDM培養基體外培養臍血CD34+細胞，在28 d培養過程中檢測CD34+細胞擴增倍數、CD34+細胞比生長速率以及集落形成率的變化趨勢，并采用熒光定量PCR檢測體外擴增過程中CD34+細胞內Bmi1和hTERT基因表達水平變化，分析以上基因表達水平與CD34+細胞擴增特性之間的關系。結果經過28 d的體外培養，CD34+細胞共擴增了（20.1 ± 3.5）倍，其占擴增后總細胞的比例由培養前的95.5% ± 2.6%下降至2.1% ± 0.4%；CD34+細胞的比生長速率和集落形成率均在培養7 d后出現明顯下降，而細胞內Bmi1和hTERT mRNA的表達水平在培養7 d時達最高，此后逐漸下降至培養前水平。結論Bmi1和hTERT基因表達與CD34+細胞體外增殖能力可能存在一定相關性。

引用本文： 葛劍云,蔡海波,杜錚,譚文松. 體外擴增過程中CD34+細胞內B細胞特異單克隆鼠白血病毒整合位點基因1和人端粒酶逆轉錄酶基因的表達. 中國修復重建外科雜志, 2012, 26(9): 1112-1116. doi: 復制

1.	1 Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med, 1998, 339(22): 1565-1577. 2 Forraz N, McGuckin CP. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif, 2011, 44 Suppl 1: 60-69.
2.	Martinez-Agosto JA, Mikkola HK, Hartenstein V, et al. The hematopoietic stem cell and its niche: a comparative view. Genes Dev, 2007, 21(23): 3044-3060.
3.	Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood, 2003, 101(12): 5061-5067.
4.	Giarratana MC, Rouard H, Dumont A, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood, 2011, 118(19): 5071-5079.
5.	Ann D, Colleen D, Bernstein ID. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood, 2011, 117(23): 6083-6090.
6.	Hofmeister CC, Zhang J, Knight KL, et al. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant, 2007, 39(1): 11-23.
7.	Law P, Traylor L, Recktenwald DJ. Cell analysis for hematopoietic stem/progenitor cells transplantation. Cytometry, 1999, 38(2): 47-52.
8.	Raaphorst FM. Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol, 2003, 24(10): 522-524.
9.	Oguro H, Yuan J, Ichikawa H, et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell, 2010, 6(3): 279-286.
10.	Wu KJ, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c-MYC. Nat Genet, 1999, 21(2): 220-224.
11.	Engelhardt M, Kumar R, Albanell J, et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood, 1997, 90(1): 182-193.
12.	Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood, 2003, 101(2): 532-540.
13.	Mohty M, Yong AS, Szydlo RM, et al. The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood, 2007, 110(1): 380-383.
14.	Fan Y, Liu Z, Fang X, et al. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues. Clin Cancer Res, 2005, 11(12): 4331-4337.
15.	Yao CL, Chu LM, Hsieh TB, et al. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical Cord blood mononuclear cells. Exp Hematol, 2004, 32(8): 720-727.
16.	Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol, 2000, 28(11): 1197-1205.
17.	Jacobs JJ, Scheijen B, Voncken JW, et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev, 1999, 13(20): 2678-2690.
18.	Iwama A, Oguro H, Negishi M, et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity, 2004, 21(6): 843-851.
19.	Dick JE. Stem cell concepts renew cancer research. Blood, 2008, 112(13): 4793-4807.

1. 1 Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med, 1998, 339(22): 1565-1577. 2 Forraz N, McGuckin CP. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif, 2011, 44 Suppl 1: 60-69.
2. Martinez-Agosto JA, Mikkola HK, Hartenstein V, et al. The hematopoietic stem cell and its niche: a comparative view. Genes Dev, 2007, 21(23): 3044-3060.
3. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood, 2003, 101(12): 5061-5067.
4. Giarratana MC, Rouard H, Dumont A, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood, 2011, 118(19): 5071-5079.
5. Ann D, Colleen D, Bernstein ID. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood, 2011, 117(23): 6083-6090.
6. Hofmeister CC, Zhang J, Knight KL, et al. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant, 2007, 39(1): 11-23.
7. Law P, Traylor L, Recktenwald DJ. Cell analysis for hematopoietic stem/progenitor cells transplantation. Cytometry, 1999, 38(2): 47-52.
8. Raaphorst FM. Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol, 2003, 24(10): 522-524.
9. Oguro H, Yuan J, Ichikawa H, et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell, 2010, 6(3): 279-286.
10. Wu KJ, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c-MYC. Nat Genet, 1999, 21(2): 220-224.
11. Engelhardt M, Kumar R, Albanell J, et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood, 1997, 90(1): 182-193.
12. Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood, 2003, 101(2): 532-540.
13. Mohty M, Yong AS, Szydlo RM, et al. The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood, 2007, 110(1): 380-383.
14. Fan Y, Liu Z, Fang X, et al. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues. Clin Cancer Res, 2005, 11(12): 4331-4337.
15. Yao CL, Chu LM, Hsieh TB, et al. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical Cord blood mononuclear cells. Exp Hematol, 2004, 32(8): 720-727.
16. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol, 2000, 28(11): 1197-1205.
17. Jacobs JJ, Scheijen B, Voncken JW, et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev, 1999, 13(20): 2678-2690.
18. Iwama A, Oguro H, Negishi M, et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity, 2004, 21(6): 843-851.
19. Dick JE. Stem cell concepts renew cancer research. Blood, 2008, 112(13): 4793-4807.

《中國修復重建外科雜志》

體外擴增過程中CD34+細胞內B細胞特異單克隆鼠白血病毒整合位點基因1和人端粒酶逆轉錄酶基因的表達

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國修復重建外科雜志》

體外擴增過程中CD34+細胞內B細胞特異單克隆鼠白血病毒整合位點基因1和人端粒酶逆轉錄酶基因的表達

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料